Jennifer L. Davis - 24 Apr 2023 Form 4 Insider Report for PROCTER & GAMBLE Co (PG)

Role
CEO - Health Care
Signature
/s/ Aaron B. Shepherd, attorney-in-fact for Jennifer L. Davis
Issuer symbol
PG
Transactions as of
24 Apr 2023
Net transactions value
-$1,837,625
Form type
4
Filing time
25 Apr 2023, 13:21:57 UTC
Previous filing
09 Dec 2022
Next filing
04 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PG Common Stock Options Exercise $1,880,004 +23,943 +60% $78.52 63,803 24 Apr 2023 Direct F1
transaction PG Common Stock Sale $3,717,630 -23,943 -38% $155.27 39,860 24 Apr 2023 Direct
holding PG Common Stock 13,164 24 Apr 2023 By Retirement Plan Trustee F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PG Restricted Stock Units Award $0 +13 +44% $0.000000 43 15 Feb 2023 Common Stock 13 Direct F3, F4
transaction PG Stock Option (Right to Buy) Options Exercise $0 -23,943 -100% $0.000000* 0 24 Apr 2023 Common Stock 23,943 $78.52 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.
F2 Reflects adjustment to PST through March 31, 2023.
F3 Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
F4 These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.